Literature DB >> 13758327

Morphine tolerance in hepatic cirrhosis.

J LAIDLAW, A E READ, S SHERLOCK.   

Abstract

Entities:  

Keywords:  LIVER CIRRHOSIS/metabolism; MORPHINE/toxicology

Mesh:

Substances:

Year:  1961        PMID: 13758327

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  29 in total

Review 1.  The central opioid system in liver disease and its complications.

Authors:  C Yurdaydin
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

2.  Medical management of portal hypertension.

Authors:  S SHERLOCK
Journal:  Proc R Soc Med       Date:  1963-04

Review 3.  Pharmacokinetics of opioids in liver disease.

Authors:  I Tegeder; J Lötsch; G Geisslinger
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

4.  Sedation in liver disease.

Authors: 
Journal:  Br Med J       Date:  1977-05-14

5.  The metabolism and bioavailability of morphine in patients with severe liver cirrhosis.

Authors:  J Hasselström; S Eriksson; A Persson; A Rane; J O Svensson; J Säwe
Journal:  Br J Clin Pharmacol       Date:  1990-03       Impact factor: 4.335

Review 6.  Acute hepatic necrosis and fulminant hepatic failure.

Authors:  B Rueff; J P Benhamou
Journal:  Gut       Date:  1973-10       Impact factor: 23.059

7.  The current status of the EEG in liver disease.

Authors:  C H Hawkes; P W Brunt
Journal:  Am J Dig Dis       Date:  1974-01

8.  Safe prescribing in liver disease.

Authors: 
Journal:  Br Med J       Date:  1973-04-28

9.  Neuropsychologic effects of diazepam related to single dose kinetics and liver function.

Authors:  J Hendel; P Elsass; P B Andreasen; E Gymoese; E F Hvidberg
Journal:  Psychopharmacology (Berl)       Date:  1976-07-09       Impact factor: 4.530

Review 10.  Drug prescribing in hepatobiliary disease.

Authors:  R K Roberts; P V Desmond; S Schenker
Journal:  Drugs       Date:  1979-03       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.